Claros Diagnostics Inc., a Woburn, Mass.-based developer of handheld urological cancer diagnostic testing systems for point-of-care use, has raised $4 million in second-round funding, according to a regulatory filing. Shareholders include Oxford Bioscience Partners, Bioventures Investors, Accelerated Technologies Partners and Commons Capital. www.clarosdx.com

Related posts:

  1. Claros Raises Series A
  2. Circulite Raising $25 Million
  3. Elixir Pharma Raises $31 Million
  4. Kleiner Backs HX Diagnostics
  5. Pathwork Diagnostics Raises $20 Million